Stille

Stille LT Debt/Equity

The Long-Term Debt to Equity Ratio of Stille (STIL.ST) as of Oct 24, 2026 is 0.13. In the previous year, Long-Term Debt to Equity Ratio was 0.05 — a change of 156.55% (higher).

LT Debt/Equity

0.13

YoY

156.55%

Last updated:

Long-Term Debt to Equity Ratio of Stille is 2025 0.13 . Long-Term Debt to Equity Ratio of Stille was 2024 0.05 . It decreases by 156.55% higher compared to the previous year.

The Stille LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2018
0.00 SEK
Jan 1, 2019
0.23 SEK
Jan 1, 2020
0.19 SEK
Jan 1, 2021
0.46 SEK
Jan 1, 2022
0.30 SEK
Jan 1, 2023
0.06 SEK
Jan 1, 2024
0.05 SEK
Jan 1, 2025
0.13 SEK
The Stille LT Debt/Equity history
YEARLT Debt/EquityYoY
0.13+156.55%
0.05-14.55%
0.06-80.23%
0.30-33.94%
0.46+136.60%
0.19-15.74%
0.23+7,927.09%
0.00-61.81%
0.01-6.55%
0.01-27.73%
0.01-75.47%
0.05—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

Long-Term Debt to Equity Ratio of Stille is 0.13 in 2025.

Long-Term Debt to Equity Ratio of Stille changed from 0.05 to 0.13, representing a 156.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio Stille since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's Stille with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Stille

All Key Metrics — Stille